View Older Stories

Dec 8, 2025 04:20AM CRISPR Therapeutics' (CRSP) BEAM Risto-Cel Data Competitive - Citizens

Dec 4, 2025 10:40AM CRISPR Therapeutics (CRSP) Ticks Higher on Takeover Speculation

Nov 17, 2025 11:13AM CRISPR Therapeutics (CRSP) call put ratio 6.5 calls to 1 put with a focus November 55 and 65 calls

Nov 17, 2025 10:59AM CRISPR Therapeutics (CRSP) Strength Said to be Tied to Unconfirmed M&A Chatter

Nov 11, 2025 04:45AM CRISPR Therapeutics' (CRSP) Drug Shows Promising Lipid Lowering Results - Citizens

Nov 11, 2025 04:24AM CRISPR Therapeutics (CRSP) PT Raised to $50 at RBC Capital

Nov 11, 2025 04:13AM CRISPR Therapeutics (CRSP) PT Lowered to $44 at Baird

Nov 11, 2025 04:03AM Oppenheimer Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)

Nov 10, 2025 03:25PM CRISPR Therapeutics (CRSP) PT Lowered to $50 at Clear Street

Nov 10, 2025 08:12AM CRISPR Therapeutics (CRSP) Tops Q3 EPS by 9c

Oct 31, 2025 09:54AM FDA Clears Way for Faster Personalized Gene Editing Treatments

Oct 27, 2025 07:59AM Intellia stock tumbles after pausing gene therapy trials on safety concerns

Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'

Oct 13, 2025 04:27AM Citizens Reiterates Market Outperform on CRISPR (CRSP), Notes In-vivo Editing Progress

Oct 10, 2025 08:00AM CRISPR presents preclinical data for gene therapy targeting rare disorder

Sep 23, 2025 12:35PM BMO Capital on CRISPR Therapeutics (CRSP): 'We Continue to Highlight the Large Oppty of FXI Space'

Sep 23, 2025 06:36AM H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)

Sep 18, 2025 03:23AM JPMorgan Starts CRISPR Therapeutics (CRSP) at Overweight

Aug 15, 2025 12:41PM Sam Altman Brain Chip Venture Is Mulling Gene Therapy Approach - Bloomberg

Aug 7, 2025 07:18AM CRISPR Therapeutics (CRSP) PT Raised to $80 at H.C. Wainwright

Aug 5, 2025 06:02AM CRISPR Therapeutics (CRSP) PT Raised to $56 at Barclays

Aug 4, 2025 04:51PM CRISPR Therapeutics (CRSP) Misses Q2 EPS by 100c

Jun 27, 2025 10:58AM CRISPR Therapeutics (CRSP) 30-day option implied volatility flat

Jun 27, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)

Jun 27, 2025 04:40AM Citizens JMP Reiterates Market Outperform Rating on CRISPR Therapeutics (CRSP)

Jun 26, 2025 04:15PM Clear Street Downgrades CRISPR Therapeutics (CRSP) to Hold

Jun 26, 2025 02:08PM Goldman Sachs Reiterates Neutral Rating on CRISPR Therapeutics (CRSP)

Jun 26, 2025 11:00AM Brookline Capital Markets Reiterates Buy Rating on CRISPR Therapeutics (CRSP)

Jun 26, 2025 10:34AM Chardan: 'We think CRSP's emergence as a credible player in the space could thus drive further valuation upside'

Jun 26, 2025 10:32AM Barclays Reiterates Equalweight Rating on CRISPR Therapeutics (CRSP)

Jun 26, 2025 10:31AM William Blair Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)

Jun 26, 2025 07:01AM CRISPR Therapeutics (CRSP) Reports Positive Additional Phase 1 Data for CTX310 Targeting ANGPTL3

Jun 18, 2025 12:15PM CRISPR Therapeutics (CRSP) gains on continued chatter

Jun 18, 2025 04:46AM Citizens JMP Reiterates Market Outperform Rating on CRISPR Therapeutics (CRSP)

Jun 18, 2025 04:45AM Eli Lilly and Verve's gene-editing M&A deal 'an important milestone' - Citizens JMP

Jun 17, 2025 11:28AM Verve Therapeutics takeover has 'positive readthrough' for gene editing space - BMO Capital

May 21, 2025 04:13AM Citizens JMP Reiterates Market Outperform Rating on CRISPR Therapeutics (CRSP)

May 19, 2025 04:15PM CRISPR Therapeutics (CRSP) and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies

May 7, 2025 06:02AM Clear Street Upgrades CRISPR Therapeutics (CRSP) to Buy

May 7, 2025 04:11AM Citizens JMP Reiterates Market Outperform Rating on CRISPR Therapeutics (CRSP)

May 6, 2025 05:31PM CRISPR Therapeutics (CRSP) Misses Q1 EPS by 37c

Apr 11, 2025 05:04AM Goldman Sachs Reiterates Neutral Rating on CRISPR Therapeutics (CRSP)

Apr 4, 2025 01:08PM FDA grants orphan drug status to Crispr's (CRSP) follicular lymphoma treatment

Mar 26, 2025 04:02PM CRISPR Therapeutics (CRSP) Announces Transition of Chief Operating Officer

Feb 14, 2025 10:38AM CRISPR Therapeutics (CRSP) PT Lowered to $82 at Citi

Feb 14, 2025 07:09AM Evercore ISI Upgrades CRISPR Therapeutics (CRSP) to Outperform

Feb 13, 2025 10:02AM CRISPR Therapeutics (CRSP) PT Lowered to $49 at Stifel

Feb 12, 2025 05:37AM TD Cowen Upgrades CRISPR Therapeutics (CRSP) to Hold

Feb 11, 2025 04:28PM CRISPR Therapeutics (CRSP) Tops Q4 EPS by 79c

Jan 22, 2025 03:16PM CRISPR Therapeutics (CRSP) call put ratio 12.5 calls to 1 put as share price up 6.1%

View Older Stories